Stock Research: Coloplast

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Coloplast

CPSE:COLO B DK0060448595
39
  • Value
    32
  • Growth
    57
  • Safety
    Safety
    26
  • Combined
    10
  • Sentiment
    68
  • 360° View
    360° View
    39
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Coloplast A/S is a healthcare company that develops, markets, and sells intimate healthcare products and services. It operates in the healthcare sector with a focus on Ostomy Care, Continence Care, Urology Care, and Wound & Skin Care. The company supplies products to hospitals, institutions, wholesalers, and pharmacies and operates in Denmark. In the last fiscal year, the company had a market cap of $21,405 million, profits of $2,729 million, and revenue of $4,038 million and 16,247 employees.

more
Index
OMX C20
Dividends Europe
Employee Focus EU
Human Rights
Renewables Users
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 22 17 21
Growth
57 72 57 29
Safety
Safety
26 10 8 68
Sentiment
68 46 49 30
360° View
360° View
39 15 8 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
17 15 28 31
Opinions Change
62 50 39 34
Pro Holdings
n/a 80 42 45
Market Pulse
75 47 78 54
Sentiment
68 46 49 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 22 17 21
Growth
57 72 57 29
Safety Safety
26 10 8 68
Combined
10 12 4 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
27 19 17 8
Price vs. Earnings (P/E)
11 7 6 7
Price vs. Book (P/B)
8 3 1 3
Dividend Yield
88 86 78 82
Value
32 22 17 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
66 71 65 58
Profit Growth
86 34 61 14
Capital Growth
51 86 36 36
Stock Returns
15 44 47 55
Growth
57 72 57 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
8 5 14 58
Refinancing
13 1 5 13
Liquidity
70 65 52 96
Safety Safety
26 10 8 68

Similar Stocks

Discover high‑ranked alternatives to Coloplast and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Repsol

BME:REP
Country: Spain
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Prosus

ENXTAM:PRX
Country: Netherlands
Industry: Internet Retail
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: